Related content

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

By Farrow D.C.  

Cancer Causes and Control, Vol. 11, Iss. 3, 2000-03 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy Using 5-Fluorouracil and Nitrocaphanum in Malignant Trophoblastic Tumor

By Wang Y.   Jiu L.   Guan Y.   Qiu D.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 416-419

Elsevier

Access to resources Recommend Favorite

Residual disease after chemotherapy in aggressive malignant lymphoma: The role of radiotherapy

By Avilés Agustin   Neri Natividad   Delgado Serafin   Pérez Felipe   Nambo M.   Cleto Sergio   Talavera Alejandra   Huerta-Guzmán Judith  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 383-387

Humana Press, Inc

Access to resources Recommend Favorite

Nutrient intake and weight development in children during chemotherapy for malignant disease

By Skolin I.   Axelsson K.   Ghannad P.   Hernell O.   Wahlin Y.B.  

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 5, 1997-09 ,pp. : 364-368

Elsevier

Access to resources Recommend Favorite

A Case of a Patient Diagnosed with Malignant Mixed Mullerian Tumor of the Ovary Who Conceived after Conservative Surgery and Adjuvant Chemotherapy

By Shibahara H.   Wakimoto E.   Mitsuo M.   Ogasawara T.   Takemura T.   Koyama K.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 363-365

Elsevier

Access to resources Recommend Favorite